Skip to main content
Premium Trial:

Request an Annual Quote

New Products: LifeCodexx's PrenaTest; RainDance's ThunderBolts

Premium

LifeCodexx's PrenaTest for noninvasive detection of fetal anueploidies is now available for use in multiple pregnancies. It can also be used following fertility treatment, such as in vitro fertilization or egg donation after the 9th week of gestation.

The firm is also offering PrenaTest express, which has a turnaround time of one week, in Germany, Austria, and Switzerland.


RainDance Technologies has launched its ThunderBolts Cancer Panel, which covers 49 cancer-related genes and runs on its RainDance Source Instrument, a $50,000 compact digital PCR system. The panel requires 1.5 hours of hands-on time and 10 ng of starting DNA and can detect mutations at a minor allele frequency below 5 percent, according to the company.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.